April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
Joanne Mortimer, M.D., named ASCO fellow, recognized for extraordinary service
March 27, 2019 | Samantha Bonar
Joanne Mortimer, M.D., was one of just 25 oncologists nationwide named a fellow of the American Society of Clinical Oncology for 2019. The distinction recognizes ASCO members for their extraordinary volunteer service, dedication and commitment to ASCO.
City of Hope doctor co-edits annual report highlighting cancer breakthroughs
January 31, 2019 | Michael Easterling
Sumanta K. Pal, M.D., was selected to serve as one of three editors of this year’s Clinical Cancer Advances, an annual report on the progress against cancer distributed by the American Society of Clinical Oncology.
Groundbreaking $2 million study will focus on family caregivers
October 15, 2018 | Maxine Nunes
City of Hope researchers have just received a $2 million grant from the National Cancer Institute to study a crucial but rarely examined aspect of patient care and quality of life — the family caregiver.
National Cancer Meeting Highlights the Expanding Role of Immunology
June 19, 2018 | Cary Presant, M.D.
At the annual 2018 meeting of the American Society of Clinical Oncology (ASCO) in Chicago, I was among the 40,000 oncologists impressed with how effective immunotherapy can be in some patients with cancer.
City of Hope Guides ASCO’s New Geriatric Cancer Recommendations
June 8, 2018 | Saundra Young
City of Hope physicians Arti Hurria, M.D., a geriatric oncologist, and William Dale, M.D., Ph.D., a geriatrician and palliative care physician, co-chaired the panel that developed the new ASCO guidelines designed to help doctors assess and manage care for older adults.
Live from ASCO: Immunotherapy Is a Revolution in Medicine
June 5, 2017 | Cary A. Presant, M.D.
Here at ASCO 2017 in Chicago, we’ve been hearing about promising new clinical trials that have shown that immunotherapy can control some of the most resistant cancers.